Published in Bone Marrow Transplant on December 04, 2006
Therapy-related myeloid leukemia. Semin Oncol (2008) 2.36
Isolated clonal cytogenetic abnormalities after high-dose therapy. Biol Blood Marrow Transplant (2014) 1.97
Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood (2009) 1.70
Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues. Cancer (2009) 1.20
Quantitative trait loci associated with susceptibility to therapy-related acute murine promyelocytic leukemia in hCG-PML/RARA transgenic mice. Blood (2008) 0.97
Therapy-related myeloid neoplasms - what have we learned so far? World J Stem Cells (2016) 0.87
Karyotypic and fluorescent in situ hybridization study of the centromere of chromosome 7 in secondary myeloid neoplasms. Rev Bras Hematol Hemoter (2011) 0.87
Second malignancies after autologous hematopoietic cell transplantation in children. Bone Marrow Transplant (2012) 0.84
Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma. Biol Blood Marrow Transplant (2014) 0.84
Therapy-related myelodysplastic syndrome: models and genetics. Biol Blood Marrow Transplant (2009) 0.78
Chemotherapy and Stem Cell Transplantation Increase p16(INK4a) Expression, a Biomarker of T-cell Aging. EBioMedicine (2016) 0.77
Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies. Oncotarget (2016) 0.75
Therapy-related acute myeloid leukemia in patients with lymphoma: A report of four cases and review of the literature. Oncol Lett (2015) 0.75
Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia (2011) 4.28
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes. Leukemia (2013) 2.85
How do cytotoxic lymphocytes kill their targets? Curr Opin Immunol (1998) 1.80
Granzyme A initiates an alternative pathway for granule-mediated apoptosis. Immunity (1999) 1.37
Recombinant retroviral systems for the analysis of drug resistant HIV. Nucleic Acids Res (1993) 0.92
POU4F1 is associated with t(8;21) acute myeloid leukemia and contributes directly to its unique transcriptional signature. Leukemia (2010) 0.90
Structural variation of the mouse natural killer gene complex. Genes Immun (2010) 0.90
Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy. Haemophilia (2007) 0.85
Alteration of the CD34+ Tf-1 beta cell line profile in response to long-term exposure to IL-15. Cytokine (1997) 0.84
Characterization of Ly-6M, a novel member of the Ly-6 family of hematopoietic proteins. Blood (2000) 0.84
SWR/J mice are susceptible to alkylator-induced myeloid leukemia. Blood Cancer J (2013) 0.76